Reports - Serological Testing Market
HealthcareSerological Testing Market
Serological Testing Market Valuation and Growth Forecast 2025-2035 by Test Type (Primary Serological Tests, Enzyme Linked Immunosorbent Assay (ELISA), Immunoflurescent Antibody Technique (IFAT), Radio Immunoassay (RIA), Secondary Serological Tests, Agglutination Tests, Complement Fixation Tests (CFT), Precipitation Tests, Serum Neutralization Tests (SNT), Toxin-antitoxin Tests, Tertiary Binding Tests) by Application (Rotavirus Infections, Hepatitis, HIV, Endotoxins, Therapeutic Drug Monitoring, Other Infectious Diseases) by End-user (Hospital and Clinics, Diagnostic Laboratories, Blood Banks, Diagnostic Laboratories, Others) by Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Industry Leaders Trust Us For Actionable Intelligence
Table of Contents
Chapter 1 Executive Dashboard
1. Strategic Imperatives
Chapter 2 Premium Insights
1. Top 3 Trends to Watch
2. Demand and Supply Trends
3. Top 3 Strategies Followed by Major Players
4. Top 3 Predictions by Vantage Market Research
5. Top Investment Pockets
6. Insights from Primary Respondents
Chapter 3 Global Serological Testing Market - Segment Analysis
1. Overview
2. Global Serological Testing Market, 2021 - 2035 (USD Million)
3. Global Serological Testing Market - by Test Type
3.1. By Primary Serological Tests
3.2. By Enzyme Linked Immunosorbent Assay (ELISA)
3.3. By Immunoflurescent Antibody Technique (IFAT)
3.4. By Radio Immunoassay (RIA)
3.5. By Secondary Serological Tests
3.6. By Agglutination Tests
3.7. By Complement Fixation Tests (CFT)
3.8. By Precipitation Tests
3.9. By Serum Neutralization Tests (SNT)
3.10. By Toxin-antitoxin Tests
3.11. By Tertiary Binding Tests
4. Global Serological Testing Market - by Application
4.1. By Rotavirus Infections
4.2. By Hepatitis
4.3. By HIV
4.4. By Endotoxins
4.5. By Therapeutic Drug Monitoring
4.6. By Other Infectious Diseases
5. Global Serological Testing Market - by End-user
5.1. By Hospital and Clinics
5.2. By Diagnostic Laboratories
5.3. By Blood Banks
5.4. By Diagnostic Laboratories
5.5. By Others
6. Global Serological Testing Market - by region
6.1. North America
6.2. Europe
6.3. Asia Pacific
6.4. Latin America
6.5. Middle East & Africa
7. Market comparative analysis
Chapter 4 North America Serological Testing Market - Segment Analysis
1. Overview
2. North America Serological Testing Market, 2021 - 2035 (USD Million)
3. North America Serological Testing Market - by Test Type
3.1. By Primary Serological Tests
3.2. By Enzyme Linked Immunosorbent Assay (ELISA)
3.3. By Immunoflurescent Antibody Technique (IFAT)
3.4. By Radio Immunoassay (RIA)
3.5. By Secondary Serological Tests
3.6. By Agglutination Tests
3.7. By Complement Fixation Tests (CFT)
3.8. By Precipitation Tests
3.9. By Serum Neutralization Tests (SNT)
3.10. By Toxin-antitoxin Tests
3.11. By Tertiary Binding Tests
4. North America Serological Testing Market - by Application
4.1. By Rotavirus Infections
4.2. By Hepatitis
4.3. By HIV
4.4. By Endotoxins
4.5. By Therapeutic Drug Monitoring
4.6. By Other Infectious Diseases
5. North America Serological Testing Market - by End-user
5.1. By Hospital and Clinics
5.2. By Diagnostic Laboratories
5.3. By Blood Banks
5.4. By Diagnostic Laboratories
5.5. By Others
Chapter 5 Europe Serological Testing Market - Segment Analysis
1. Overview
2. Europe Serological Testing Market, 2021 - 2035 (USD Million)
3. Europe Serological Testing Market - by Test Type
3.1. By Primary Serological Tests
3.2. By Enzyme Linked Immunosorbent Assay (ELISA)
3.3. By Immunoflurescent Antibody Technique (IFAT)
3.4. By Radio Immunoassay (RIA)
3.5. By Secondary Serological Tests
3.6. By Agglutination Tests
3.7. By Complement Fixation Tests (CFT)
3.8. By Precipitation Tests
3.9. By Serum Neutralization Tests (SNT)
3.10. By Toxin-antitoxin Tests
3.11. By Tertiary Binding Tests
4. Europe Serological Testing Market - by Application
4.1. By Rotavirus Infections
4.2. By Hepatitis
4.3. By HIV
4.4. By Endotoxins
4.5. By Therapeutic Drug Monitoring
4.6. By Other Infectious Diseases
5. Europe Serological Testing Market - by End-user
5.1. By Hospital and Clinics
5.2. By Diagnostic Laboratories
5.3. By Blood Banks
5.4. By Diagnostic Laboratories
5.5. By Others
Chapter 6 Asia Pacific Serological Testing Market - Segment Analysis
1. Overview
2. Asia Pacific Serological Testing Market, 2021 - 2035 (USD Million)
3. Asia Pacific Serological Testing Market - by Test Type
3.1. By Primary Serological Tests
3.2. By Enzyme Linked Immunosorbent Assay (ELISA)
3.3. By Immunoflurescent Antibody Technique (IFAT)
3.4. By Radio Immunoassay (RIA)
3.5. By Secondary Serological Tests
3.6. By Agglutination Tests
3.7. By Complement Fixation Tests (CFT)
3.8. By Precipitation Tests
3.9. By Serum Neutralization Tests (SNT)
3.10. By Toxin-antitoxin Tests
3.11. By Tertiary Binding Tests
4. Asia Pacific Serological Testing Market - by Application
4.1. By Rotavirus Infections
4.2. By Hepatitis
4.3. By HIV
4.4. By Endotoxins
4.5. By Therapeutic Drug Monitoring
4.6. By Other Infectious Diseases
5. Asia Pacific Serological Testing Market - by End-user
5.1. By Hospital and Clinics
5.2. By Diagnostic Laboratories
5.3. By Blood Banks
5.4. By Diagnostic Laboratories
5.5. By Others
Chapter 7 Latin America Serological Testing Market - Segment Analysis
1. Overview
2. Latin America Serological Testing Market, 2021 - 2035 (USD Million)
3. Latin America Serological Testing Market - by Test Type
3.1. By Primary Serological Tests
3.2. By Enzyme Linked Immunosorbent Assay (ELISA)
3.3. By Immunoflurescent Antibody Technique (IFAT)
3.4. By Radio Immunoassay (RIA)
3.5. By Secondary Serological Tests
3.6. By Agglutination Tests
3.7. By Complement Fixation Tests (CFT)
3.8. By Precipitation Tests
3.9. By Serum Neutralization Tests (SNT)
3.10. By Toxin-antitoxin Tests
3.11. By Tertiary Binding Tests
4. Latin America Serological Testing Market - by Application
4.1. By Rotavirus Infections
4.2. By Hepatitis
4.3. By HIV
4.4. By Endotoxins
4.5. By Therapeutic Drug Monitoring
4.6. By Other Infectious Diseases
5. Latin America Serological Testing Market - by End-user
5.1. By Hospital and Clinics
5.2. By Diagnostic Laboratories
5.3. By Blood Banks
5.4. By Diagnostic Laboratories
5.5. By Others
Chapter 8 Middle East & Africa Serological Testing Market - Segment Analysis
1. Overview
2. Middle East & Africa Serological Testing Market, 2021 - 2035 (USD Million)
3. Middle East & Africa Serological Testing Market - by Test Type
3.1. By Primary Serological Tests
3.2. By Enzyme Linked Immunosorbent Assay (ELISA)
3.3. By Immunoflurescent Antibody Technique (IFAT)
3.4. By Radio Immunoassay (RIA)
3.5. By Secondary Serological Tests
3.6. By Agglutination Tests
3.7. By Complement Fixation Tests (CFT)
3.8. By Precipitation Tests
3.9. By Serum Neutralization Tests (SNT)
3.10. By Toxin-antitoxin Tests
3.11. By Tertiary Binding Tests
4. Middle East & Africa Serological Testing Market - by Application
4.1. By Rotavirus Infections
4.2. By Hepatitis
4.3. By HIV
4.4. By Endotoxins
4.5. By Therapeutic Drug Monitoring
4.6. By Other Infectious Diseases
5. Middle East & Africa Serological Testing Market - by End-user
5.1. By Hospital and Clinics
5.2. By Diagnostic Laboratories
5.3. By Blood Banks
5.4. By Diagnostic Laboratories
5.5. By Others
Chapter 9 Key Market Dynamics
1. Introduction
2. Market Drivers
3. Market Restraints
4. Market Opportunities
5. Porter's Five Forces Analysis
6. PEST Analysis
7. Regulatory Landscape
8. Technology Landscape
9. Regional Market Trends
Chapter 10 COVID 19 Impact Analysis
1. Key strategies undertaken by companies to tackle COVID-19
2. Short term dynamics
3. Long term dynamics
Chapter 11 Marketing Strategy Analysis
1. Marketing Channel
2. Direct Marketing
3. Indirect Marketing
4. Marketing Channel Development Trends
Chapter 12 Competitive Landscape
1. Competition Matrix - 2021
2. Company Market Share Analysis - 2021
3. Key Company Activities, 2018 - 2021
4. Strategic Developments - Heat Map Analysis
5. Company Offering Evaluation
6. Company Regional Presence Evaluation
Chapter 13 Company Profiles
1. Advanced Diagnostics Inc.
2. Randox Laboratories Ltd.
3. Cellex Inc.
4. Abbott
5. Eurofins Scientific
6. Becton Dickinson and Company (BD)
7. Thermo Fisher Scientific Inc.
8. Quest Diagnostics
9. F. Hoffmann La-Roche Ltd.
10. BioMedomics Inc.
11. Beckman Coulter Inc.
Chapter 14 Key Primary Respondents - VERBATIM
Chapter 15 Discussion Guide
Chapter 16 Customization Offered
Chapter 17 Annexure
Chapter 18 List of Figures
Chapter 19 List of Tables
Chapter 20 List of Abbreviations
FAQ‘s
Related Reports
Contact
Toll Free Number+1 (877) 462-2282
© 2025 Vantage Market Research. All right reserved
Secured By